
Forward to Fusion
As it pursues energy’s Holy Grail, TAE Technologies seeks to market decades of R&D.
As it pursues energy’s Holy Grail, TAE Technologies seeks to market decades of R&D.
A private venture pursuing fusion power technology has stumbled on a potent way to kill cancer cells while methodically marching toward the Holy Grail of energy production.
Technology developed to try to crack the code of nuclear fusion — that elusive type of nuclear energy that powers the sun — is now being repurposed to kill cancer.
TAE Technologies has spawned a spinoff focusing on a novel type of cancer therapy. TAE Life Sciences will take advantage of the company’s accelerator-based beam technology.
TAE Life Sciences leverages fusion energy breakthroughs to provide technology for a promising, investigative cancer treatment.
February 2018 | J.A. Romero | Nature Communications | Paper
Active control of field reversed configuration (FRC) devices requires a method to determine the flux surface geometry and dynamic properties of the plasma during both transient and steady-state conditions.
CEO Steven Specker said TAE may have other spin-off companies up its sleeve as the company works to make its fusion dream come true. “We like the word ‘disruptive.’”
The need for safe, sustainable, limitless energy is as great now as it’s ever been, both to mitigate climate concerns and because creating clean energy resources raises global living standards for everyone. Access to clean energy, particularly in developing countries, leads to economic equality, energy independence, job creation and overall geopolitical stability.
CEO Steven Specker said TAE may have other spin-off companies up its sleeve as the company works to make its fusion dream come true. “We like the word ‘disruptive.’”
TAE Technologies, the California-based fusion company, said its latest and greatest plasma generator has exceeded the headline-grabbing performance of its previous machine.